Liver Neoplasms

"Liver Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the LIVER.

Descriptor ID	D008113
MeSH Number(s)	C04.588.274.623 C06.301.623 C06.552.697
Concept/Terms	Liver Neoplasms Liver Neoplasms Neoplasms, Hepatic Neoplasms, Liver Liver Neoplasm Neoplasm, Liver Hepatic Neoplasms Hepatic Neoplasm Neoplasm, Hepatic Cancer of Liver Cancer of Liver Hepatocellular Cancer Cancers, Hepatocellular Hepatocellular Cancers Hepatic Cancer Cancer, Hepatic Cancers, Hepatic Hepatic Cancers Liver Cancer Cancer, Liver Cancers, Liver Liver Cancers Cancer of the Liver Cancer, Hepatocellular

Below are MeSH descriptors whose meaning is more general than "Liver Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Digestive System Neoplasms [C04.588.274]
Liver Neoplasms [C04.588.274.623]
Digestive System Diseases [C06]
Digestive System Neoplasms [C06.301]
Liver Neoplasms [C06.301.623]
Liver Diseases [C06.552]
Liver Neoplasms [C06.552.697]

Below are MeSH descriptors whose meaning is more specific than "Liver Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Liver Neoplasms" by people in this website by year, and whether "Liver Neoplasms" was a major or minor topic of these publications.

Bar chart showing 367 publications over 30 distinct years, with a maximum of 23 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	3	1	4
1997	2	2	4
1998	6	1	7
1999	2	2	4
2000	5	1	6
2001	3	1	4
2002	13	4	17
2003	5	2	7
2004	2	4	6
2005	11	3	14
2006	11	2	13
2007	15	3	18
2008	19	3	22
2009	6	1	7
2010	6	2	8
2011	9	5	14
2012	18	0	18
2013	15	2	17
2014	15	3	18
2015	10	0	10
2016	9	1	10
2017	16	1	17
2018	13	4	17
2019	20	3	23
2020	14	2	16
2021	12	1	13
2022	17	1	18
2023	14	0	14
2024	18	1	19
2025	2	0	2

Below are the most recent publications written about "Liver Neoplasms" by people in Profiles.

Shin AE, Sugiura K, Kariuki SW, Cohen DA, Flashner SP, Klein-Szanto AJ, Nishiwaki N, De D, Vasan N, Gabre JT, Lengner CJ, Sims PA, Rustgi AK. LIN28B-mediated PI3K/AKT pathway activation promotes metastasis in colorectal cancer models. J Clin Invest. 2025 Apr 15; 135(8).

View in: PubMed
Lyshchik A, Kuon Yeng Escalante C, Siu Xiao T, Piscaglia F, Kono Y, Medellin-Kowalewski A, Rodgers SK, Planz V, Kamaya A, Fetzer DT, Berzigotti A, Radu IP, Sidhu PS, Wessner CE, Bradigan K, Eisenbrey JR, Forsberg F, Wilson SR. Contrast-enhanced US of High-Risk Indeterminate Focal Liver Observations Categorized as LR-4 or LR-M at CT/MRI. Radiology. 2025 01; 314(1):e240916.

View in: PubMed
Li Y, Lam SSK, Gao Y, Shore E, Anderson DW, Hode T, Martin RC. Enhancing the Immunotherapeutic Effect by IP-001 and Irreversible Electroporation in Mouse Oligometastatic Models of Pancreatic Adenocarcinoma. Ann Surg Oncol. 2025 Apr; 32(4):2786-2798.

View in: PubMed
Kamaya A, Fetzer DT, Seow JH, Burrowes DP, Choi HH, Dawkins AA, Fung C, Gabriel H, Hong CW, Khurana A, McGillen KL, Morgan TA, Sirlin CB, Tse JR, Rodgers SK. LI-RADS US Surveillance Version 2024 for Surveillance of Hepatocellular Carcinoma: An Update to the American College of Radiology US LI-RADS. Radiology. 2024 12; 313(3):e240169.

View in: PubMed
Rodgers SK, Fetzer DT, Seow JH, McGillen K, Burrowes DP, Fung C, Udare AS, Wilson SR, Kamaya A. Optimizing US for HCC surveillance. Abdom Radiol (NY). 2025 06; 50(6):2453-2463.

View in: PubMed
Heald J, Fetzer DT, Rodgers S, Jain V, Fung A, Liu X, Wilson S, Kamaya A, Marks RM. Patient centered HCC surveillance - complementary roles of ultrasound and CT/MRI. Abdom Radiol (NY). 2025 05; 50(5):2088-2096.

View in: PubMed
Cron DC, Mazur RD, Bhan I, Adler JT, Yeh H. Sex and Size Disparities in Access to Liver Transplant for Patients With Hepatocellular Carcinoma. JAMA Surg. 2024 Nov 01; 159(11):1291-1298.

View in: PubMed
Asano K, Kageyama K, Yamamoto A, Jogo A, Nakano M, Murai K, Yukawa-Muto Y, Odagiri N, Kotani K, Kozuka R, Kawamura E, Fujii H, Uchida-Kobayashi S, Enomoto M, Kawada N, Miki Y. Predictors of Immediate Deterioration of the Child-Pugh Classification From A to B After Transcatheter Arterial Chemo-Embolization for Treatment-Naive Hepatocellular Carcinoma. Cancer Med. 2024 Nov; 13(21):e70367.

View in: PubMed
Kuon Yeng Escalante CM, Siu Xiao T, Kono Y, Piscaglia F, Wilson SR, Medellin A, Rodgers SK, Planz V, Kamaya A, Fetzer DT, Berzigotti A, Sidhu PS, Wessner CE, Bradigan K, Eisenbrey JR, Forsberg F, Lyshchik A. Inter-Reader Agreement for Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System Major Features and Final Categorization: A Subanalysis From a Prospective Multicenter Study. J Ultrasound Med. 2025 Feb; 44(2):349-357.

View in: PubMed
Siu Xiao T, Kuon Yeng Escalante CM, Tahmasebi A, Kono Y, Piscaglia F, Wilson SR, Medellin-Kowalewski A, Rodgers SK, Planz V, Kamaya A, Fetzer DT, Berzigotti A, Radu IP, Sidhu PS, Wessner CE, Bradigan K, Eisenbrey JR, Forsberg F, Lyshchik A. Combining CEUS and CT/MRI LI-RADS major imaging features: diagnostic accuracy for classification of indeterminate liver observations in patients at risk for HCC. Abdom Radiol (NY). 2025 05; 50(5):2066-2077.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement